Cargando…
Nutrient Condition in the Microenvironment Determines Essential Metabolisms of CD8(+) T Cells for Enhanced IFNγ Production by Metformin
Metformin (Met), a first-line drug for type 2 diabetes, lowers blood glucose levels by suppressing gluconeogenesis in the liver, presumably through the liver kinase B1-dependent activation of AMP-activated protein kinase (AMPK) after inhibiting respiratory chain complex I. Met is also implicated as...
Autores principales: | Chao, Ruoyu, Nishida, Mikako, Yamashita, Nahoko, Tokumasu, Miho, Zhao, Weiyang, Kudo, Ikuru, Udono, Heiichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277540/ https://www.ncbi.nlm.nih.gov/pubmed/35844589 http://dx.doi.org/10.3389/fimmu.2022.864225 |
Ejemplares similares
-
Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
por: Nishida, Mikako, et al.
Publicado: (2021) -
Attenuation of CD4(+) CD25(+) Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug
por: Kunisada, Yuki, et al.
Publicado: (2017) -
Metformin induces CD11b(+)-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects
por: Uehara, Takenori, et al.
Publicado: (2018) -
Metformin Promotes the Protection of Mice Infected With Plasmodium yoelii Independently of γδ T Cell Expansion
por: Miyakoda, Mana, et al.
Publicado: (2018) -
The Roles of CD8(+) and CD4(+) Cells in Tumor Rejection
por: Udono, Heiichiro, et al.
Publicado: (1989)